The George Washington University Hematology Update Symposium 2026 brings malignant and nonmalignant blood disorders into a focused one-day review. Its seven scientific lectures address myeloproliferative neoplasms and CMML, multiple myeloma, coagulation disorders, AML, CLL, lymphoma and bone marrow failure. Directed by Robert S. Siegel, MD, the symposium emphasizes interpreting diagnostic and treatment developments within clinical practice. The original meeting took place February 28, 2026, at the Hyatt Regency Bethesda in Maryland. It is relevant to hematologists, oncologists, hematopathologists and internal medicine professionals who want to review disease-specific evidence and the clinical considerations presented by the faculty.
Learning Objectives
These retained objectives combine the stated course goals with educational themes in the supplied program description.
- Discuss recent diagnostic and therapeutic advances in hematology, including developments affecting hematologic malignancies and nonmalignant blood disorders.
- Evaluate contemporary scientific evidence involving malignant hematologic diseases, coagulation abnormalities, and bone marrow disorders.
- Apply current clinical evidence, practice recommendations, and diagnostic tools to improve patient assessment and individualized treatment planning.
- Formulate evidence-based approaches to complex hematologic conditions, including leukemia, lymphoma, plasma cell malignancies, and bone marrow failure syndromes.
- Review developments in the diagnosis, classification, risk assessment, and management of myeloproliferative neoplasms and chronic myelomonocytic leukemia.
- Evaluate evolving treatment strategies for multiple myeloma and related plasma cell disorders.
- Recognize common and complex coagulation abnormalities and consider appropriate diagnostic and therapeutic approaches.
- Review clinically important advances in acute myeloid leukemia and chronic lymphocytic leukemia.
- Examine contemporary diagnostic and treatment considerations for lymphoma.
- Identify major categories of bone marrow failure and understand principles of clinical evaluation and treatment selection.
Topics
- Welcome- Siegel RS
- Myeloproliferative Neoplasms
- Multiple Myeloma
- Disorders of Coagulation
- Acute Myeloid Leukemia
- Chronic Lymphocytic Leukemia
- Lymphoma
- Bone Marrow Failure
- Closing Adjournment
Faculty
Course director: Robert S. Siegel, MD, Professor of Medicine and Associate Director for Education and Training, GW Cancer Center.
- Robert S. Siegel, MD — The George Washington University
- Ayalew Tefferi, MD — Mayo Clinic
- Kenneth Anderson, MD — Dana-Farber Cancer Institute / Harvard Medical School
- Kenneth A. Bauer, MD — Harvard Medical School / Beth Israel Deaconess Medical Center
- Samah Nassereddine, MD — The George Washington University
- Imad A. Tabbara, MD, FACP — The George Washington University / Anne Arundel Medical Center
- Nina Delaney Wagner-Johnston, MD — Johns Hopkins University
- Mrinal S. Patnaik, MD — Mayo Clinic
Original Program and Package Scope
The original live activity ran from 8:00 AM to 4:00 PM Eastern Time and offered up to 7 AMA PRA Category 1 Credits™ and 7 ABIM MOC points to eligible participants. These benefits, university registration, live attendance, accounts and official platform access are not included with this purchase. The provider’s electronic syllabus, PDF handouts and archived recordings do not establish the exact inventory of this separate store package.



